IL6 and type 1 diabetes mellitus: This prospective study assessed the long‐term prognostic value of suPAR, IL‐6, and their combination regarding all‐cause mortality and MACE in a large (n = 962) population of individuals with T1D without known cardiovascular diseases from the Capital Region of Denmark.